Kadcyla Wins FDA Approval For HER2 Breast Cancer

A new drug will soon be available to treat HER2-positive metastatic breast cancer. Made by Genentech, it will be known as Kadcyla (ado-trastuzumab emtansine). This drug is a highly targeted ...Read Full Post
Source: About.com Breast Cancer - Category: Cancer & Oncology Source Type: news